14-3-3σ is required to prevent mitotic catastrophe after DNA damage

Chan, Timothy A., Hermeking, Heiko, Lengauer, Christoph, Kinzler, Kenneth W., Vogelstein, Bert·1999·Nature
DOI 10.1038/44188

Cited by (895)

Items 101–200 of 895

  1. p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
    Smits, Veronique A.J., Klompmaker, Rob, Vallenius, Tea, Rijksen, Gert, Mäkelä, Tomi P., Medema, René H. · 2000 · Journal of Biological Chemistry
  2. Targeting the Mitotic Catastrophe Signaling Pathway in Cancer
    Margaret M. Mc Gee · 2015 · Mediators of Inflammation
  3. 14-3-3 Proteins find new partners in plant cell signalling
    MICHAEL R. ROBERTS · 2003 · Trends in Plant Science
  4. Transcriptional Profiling of Krüppel-like Factor 4 Reveals a Function in Cell Cycle Regulation and Epithelial Differentiation
    Xinming Chen, Erika M. Whitney, Shu Y Gao, Vincent W. Yang · 2003 · Journal of Molecular Biology
  5. Genotoxic Anti-Cancer Agents and Their Relationship to DNA Damage, Mitosis, and Checkpoint Adaptation in Proliferating Cancer Cells
    Lucy H. Swift, Roy M. Golsteyn · 2014 · International Journal of Molecular Sciences
  6. ATM, ATR and DNA-PKcs kinases—the lessons from the mouse models: inhibition ≠ deletion
    Demis Menolfi, Shan Zha · 2020 · Cell & Bioscience
  7. Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins
    Sarah E. M. Meek, William S. Lane, Helen M. Piwnica-Worms · 2004 · Journal of Biological Chemistry
  8. Tumour suppression by p53: the importance of apoptosis and cellular senescence
    Valentina Zuckerman, Kamil Wolyniec, Ronit Vogt Sionov, Sue Haupt, Ygal Haupt · 2009 · The Journal of Pathology
  9. Targeting CDK1 in cancer: mechanisms and implications
    Qiushi Wang, Ann M. Bode, Tianshun Zhang · 2023 · npj Precision Oncology
  10. Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 Phase
    Rieko Ohki, Jiro Nemoto, Hideki Murasawa, Eri Oda, Johji Inazawa, Nobuyuki Tanaka, Tadatsugu Taniguchi · 2000 · Journal of Biological Chemistry
  11. Virus-mediated killing of cells that lack p53 activity
    Raj, Kenneth, Ogston, Phyllis, Beard, Peter · 2001 · Nature
  12. Apoptosis regulation in tetraploid cancer cells
    Maria Castedo, Arnaud Coquelle, Sonia Vivet, Ilio Vitale, Audrey Kauffmann, Philippe Dessen, Marie O. Péquignot, Noëlia Casares, Alexandre Valent, Shahul Mouhamad et al. · 2006 · The EMBO Journal
  13. DNA methylation in breast cancer.
    Xiaowei Yang, Liying Yan, Nancy E. Davidson · 2001 · Endocrine Related Cancer
  14. Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
    Hiroyuki Inuzuka, Alan Tseng, Daming Gao, Bo Zhai, Qing Hua Zhang, Shavali Shaik, Lixin Wan, Xiaolu A. Cambronne, Caroline S. Mock, Haoqiang Yin et al. · 2010 · Cancer Cell
  15. Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G 2 /M Phase, and Protection from Apoptosis
    Artur Słupianek, Grażyna Hoser, Ireneusz Majsterek, Agnieszka Bronisz, Maciej Tadeusz Malecki, Janusz Błasiak, Richard A. Fishel, Tomasz Skórski · 2002 · Molecular and Cellular Biology
  16. p21-Mediated Nuclear Retention of Cyclin B1-Cdk1 in Response to Genotoxic Stress
    Charrier-Savournin, Fabienne Baus, Château, Marie-Thérèse, Gire, Véronique, Sedivy, John, Piette, Jacques, Dulić, Vjekoslav · 2004 · Molecular Biology of the Cell
  17. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
    Hiromu Suzuki, Fumio Itoh, Maho Toyota, Takefumi Kikuchi, H Kakiuchi, K Imai · 2000 · PubMed
  18. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
    A Olsson, Claudia Manzl, Andreas Strasser, Andreas Villunger · 2007 · Cell Death and Differentiation
  19. UV‐induced DNA damage initiates release of MMP‐1 in human skin
    Kelly K. Dong, Niusha Damaghi, Stephanie D. Picart, Nelli G. Markova, Kei Obayashi, Yuri Okano, Hitoshi Masaki, Susanne Grether‐Beck, Jean Krutmann, Kenneth A. Smiles et al. · 2008 · Experimental Dermatology
  20. Ku86 is essential in human somatic cells
    Gang Li, Caron Nelsen, Eric A. Hendrickson · 2002 · Proceedings of the National Academy of Sciences
  21. Motion trajectory prediction based on a CNN-LSTM sequential model
    Guo Xie, Anqi Shangguan, Rong Fei, Wenjiang Ji, Weigang Ma, Xinhong Hei · 2020 · Science China Information Sciences
  22. Untitled work
    2001 · PubMed
  23. Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancers
    M.-H. Lee, Heng Yang · 2001 · Cellular and Molecular Life Sciences
  24. 14-3-3 proteins and the response to abiotic and biotic stress
    MICHAEL R. ROBERTS, Julio Salinas, David Brian Collinge · 2002 · Plant Molecular Biology
  25. Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization
    Steven J.T. Jackson · 2003 · Carcinogenesis
  26. The dark side of a tumor suppressor: anti-apoptotic p53
    Reiner U. Jänicke, Dennis Sohn, Klaus Schulze‐Osthoff · 2008 · Cell Death and Differentiation
  27. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray
    Olivier C. Maes, Suying Xu, Bo Yu, Howard Mark Chertkow, Eugenia Wang, Hyman M. Schipper · 2006 · Neurobiology of Aging
  28. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.
    Jung-Sik Kim, Heather Crooks, Tatiana Dracheva, Tagvor G. Nishanian, Baljit Singh, Jin Jen, Todd A. Waldman · 2002 · PubMed
  29. Pancreatic Carcinogenesis
    Jan-Bart M. Koorstra, Steven R. Hustinx, G. Johan A. Offerhaus, Anirban Maitra · 2008 · Pancreatology
  30. Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer
    Anne Benzinger, Nemone Muster, Heike Koch, John R. Yates, Heiko Hermeking · 2005 · Molecular & Cellular Proteomics
  31. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells
    Kalli Koniaras, Andrew R. Cuddihy, Helen Christopoulos, Annette Hogg, Matthew J. O’Connell · 2001 · Oncogene
  32. Crystal Structure of a Superstable Mutant of Human p53 Core Domain
    Andreas C. Joerger, Mark D. Allen, Alan Roy Fersht · 2004 · Journal of Biological Chemistry
  33. The enigmatic effects of caffeine in cell cycle and cancer
    Ann M. Bode, Zigang Dong · 2006 · Cancer Letters
  34. Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway
    Gemma K. Alderton, Hans Joenje, Raymonda Varon, Anders Dupont Børglum, Penny Ann Jeggo, Mark O’Driscoll · 2004 · Human Molecular Genetics
  35. Isoform‐specific expression of 14‐3‐3 proteins in human lung cancer tissues
    Wenqing Qi, Xiaobing Liu, Dianhua Qiao, Jesse D. Martinez · 2004 · International Journal of Cancer
  36. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe
    Maria Castedo, Jean‐Luc Perfettini, Thomas Roumier, Kenichi Yakushijin, David A. Horne, René H. Medema, Guido Kroemer · 2004 · Oncogene
  37. p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein
    Vanesa Gottifredi, Orit Karni-Schmidt, Sheau-Yann Shieh, Carol L. Prives · 2001 · Molecular and Cellular Biology
  38. NF-Y Mediates the Transcriptional Inhibition of thecyclin B1, cyclin B2, and cdc25CPromoters upon Induced G2 Arrest
    Isabella Manni, Giuseppina Mazzaro, Aymone Gurtner, Roberto Mantovani, Ulrike Haugwitz, Karen Krause, Kurt Engeland, Ada Sacchi, Silvia Soddu, Giulia Piaggio · 2001 · Journal of Biological Chemistry
  39. The tumour suppressor protein p53 can repress transcription of cyclin B
    Kerstin Krause · 2000 · Nucleic Acids Research
  40. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents
    Masayuki Nitta, Osamu Kobayashi, Shinobu Honda, Toru Hirota, Shinji Kuninaka, Tomotoshi Marumoto, Yukitaka Ushio, Hideyuki Saya · 2004 · Oncogene
  41. Integrating stress-response and cell-cycle checkpoint pathways
    Amanda K Pearce, Timothy C. Humphrey · 2001 · Trends in Cell Biology
  42. Runx2 Regulates Endochondral Ossification Through Control of Chondrocyte Proliferation and Differentiation
    Haiyan Chen, Farah Y. Ghori-Javed, Harunur Rashid, Mitra Adhami, Rosa A. Serra, Soraya Elisa Gutierrez, Amjad Javed · 2014 · Journal of Bone and Mineral Research
  43. Role of 14–3–3 Proteins in Eukaryotic Signaling and Development
    Dawn L. Darling, Jessica Yingling, Anthony J. Wynshaw-Boris · 2005 · Current topics in developmental biology/Current Topics in Developmental Biology
  44. ATM function and telomere stability
    Pandita, Tej K · 2002 · Oncogene
  45. The role of DNA damage responses in p53 biology
    Daniel Speidel · 2015 · Archives of Toxicology
  46. DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
    Selvon St. Clair, Luciana E. Giono, Shohreh Varmeh, Lois Resnick‐Silverman, Wen-jun Liu, Abhilash Padi, Jayasri Dastidar, Andrea DaCosta, Melissa Mattia, James J. Manfredi · 2004 · Molecular Cell
  47. p53 Regulation of G <sub>2</sub> Checkpoint Is Retinoblastoma Protein Dependent
    Flatt, Patricia M., Tang, Luo Jia, Scatena, Caroline D., Szak, Suzanne T., Pietenpol, Jennifer A. · 2000 · Molecular and Cellular Biology
  48. Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer
    Xiao Ling Li, Murugan Subramanian, Matthew F. Jones, Ritu Chaudhary, Deepak Kumar Singh, Xinying Zong, Berkley E. Gryder, Sivasish Sindri, Min Mo, Aaron J. Schetter et al. · 2017 · Cell Reports
  49. Sp1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p21 Gene by the p53 Tumor Suppressor Protein
    George Koutsodontis, Ioannis K. Tentes, Paraskevi Papakosta, Aristidis Moustakas, Dimitris Kardassis · 2001 · Journal of Biological Chemistry
  50. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
    Anne‐Sophie Vercoutter‐Edouart, Jérôme Lemoine, Xuefen Le Bourhis, Louis Hornez, B. Boilly, Victor Nurcombe, Françoise Révillion-Carette, Jean‐Philippe Peyrat, Hubert Hondermarck · 2001 · PubMed
  51. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma
    Marta Persson, Ywonne Andrén, Christopher A. Moskaluk, Henry F. Frierson, Susanna L. Cooke, Philip A. Futreal, Teresia Kling, Sven Nelander, Anders Nordkvist, Fredrik Persson et al. · 2012 · Genes Chromosomes and Cancer
  52. The G2/M Regulator 14-3-3ς Prevents Apoptosis through Sequestration of Bax
    Temesgen Samuel, Hans Oliver Weber, Pia Rauch, Berlinda Verdoodt, Jason-Thomas Eppel, Andy McShea, Heiko Hermeking, Jens Oliver Funk · 2001 · Journal of Biological Chemistry
  53. Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo
    Maliha Chaudhri, Marie Scarabel, Alastair Aitken · 2003 · Biochemical and Biophysical Research Communications
  54. Sulforaphane Inhibits Human MCF-7 Mammary Cancer Cell Mitotic Progression and Tubulin Polymerization
    Steven J.T. Jackson, Keith W. Singletary · 2004 · Journal of Nutrition
  55. Delayed Wound Healing in Keratin 6a Knockout Mice
    Sonja M. Wojcik, Donnie S. Bundman, Dennis R. Roop · 2000 · Molecular and Cellular Biology
  56. Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells
    Lien‐Chai Chiang, Lean‐Teik Ng, I-Cheng Lin, Po‐Lin Kuo, Chun‐Ching Lin · 2005 · Cancer Letters
  57. Strategies for manipulating the p53 pathway in the treatment of human cancer
    Ted R. Hupp, David Philip Lane, Kathryn L. Ball · 2000 · Biochemical Journal
  58. Fools rush in
    Helen M. Piwnica-Worms · 1999 · Nature
  59. Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers
    Hirotaka Osada, Yoshio Tatematsu, Yasushi Yatabe, Taku Nakagawa, Hiroyuki Konishi, Tomoko Harano, Ekmel Tezel, Minoru Takada, Takashi Takahashi · 2002 · Oncogene
  60. Stem cells, senescence, neosis and self-renewal in cancer.
    Rengaswami Rajaraman, Duane L. Guernsey, Murali M Rajaraman, Selva R Rajaraman · 2006 · Cancer Cell International
  61. p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels
    Narayanan Gopalakrishna Iyer, Suet‐Feung Chin, Hi̇lal Özdağ, Yataro Daigo, De‐En Hu, Massimiliano Cariati, Kevin Michael Brindle, Samuel A. J. R. Aparicio, Carlos Caldas · 2004 · Proceedings of the National Academy of Sciences
  62. 14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis
    Brett Cornell, Kazuhito Toyo‐oka · 2017 · Frontiers in Molecular Neuroscience
  63. DNA damage induces two distinct modes of cell death in ovarian carcinomas
    Helin Vakifahmetoglu, Magnus Olsson, C Tamm, N Heidari, Sten Orrenius, Boris Zhivotovsky · 2007 · Cell Death and Differentiation
  64. p63 and epithelial biology
    Christopher E. Barbieri, Jennifer A. Pietenpol · 2006 · Experimental Cell Research
  65. Bioactive materials to control cell cycle
    Larry L. Hench, Julia Margaret Polak, Ioannis D. Xynos, Lee D.K. Buttery · 2000 · Materials Research Innovations
  66. Dual-specificity phosphatases as targets for antineoplastic agents
    Michael A. Lyon, Alexander P. Ducruet, Peter Wipf, John Stephen Lazo · 2002 · Nature Reviews Drug Discovery
  67. Depletion of Chk1 Leads to Premature Activation of Cdc2-cyclin B and Mitotic Catastrophe
    Hiroyuki Niida, Shinji Tsuge, Yuko Katsuno, Akimitsu Konishi, Naoki Takeda, Makoto Nakanishi · 2005 · Journal of Biological Chemistry
  68. BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability
    Tomasz Skórski · 2002 · Oncogene
  69. Oncogenic tyrosine kinases and the dna-damage response
    Tomasz Skórski · 2002 · Nature reviews. Cancer
  70. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies
    Éric Solary, Nathalie M Droin, Ali Bettaı̈eb, Laurent Corcos, Marie‐Thérèse Dimanche‐Boitrel, Carmen Garrido · 2000 · Leukemia
  71. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1
    Rüdiger Göke, Peter Josef Barth, A. Schmidt, Birgit Samans, Brigitte Lankat–Buttgereit · 2004 · American Journal of Physiology-Cell Physiology
  72. An Approach to Studying Lung Cancer-related Proteins in Human Blood
    Ting Xiao, Wantao Ying, Lie Li, Zhi Hu, Ying Ma, Liyan Jiao, Jinfang Ma, Yun Cai, Dongmei Lin, Suping Guo et al. · 2005 · Molecular & Cellular Proteomics
  73. 14-3-3 adaptor proteins recruit AID to 5′-AGCT-3′–rich switch regions for class switch recombination
    Zhenming Xu, Zsolt Zoltán Fülöp, Guikai Wu, Egest James Pone, Jinsong Zhang, Thach Mai, Lisa M. Black Thomas, Ahmed Ali Al-Qahtani, Clayton A. White, Seok‐Rae Park et al. · 2010 · Nature Structural & Molecular Biology
  74. Non-Canonical Cell Death Induced by p53
    Atul Ranjan, Tomoo Iwakuma · 2016 · International Journal of Molecular Sciences
  75. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis
    Akira Masuda, Takashi Takahashi · 2002 · Oncogene
  76. A link between mitotic defects and mitotic catastrophe: detection and cell fate
    Elena V. Sazonova, Svetlana V. Petrichuk, Gelina S. Kopeina, Boris Zhivotovsky · 2021 · Biology Direct
  77. Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation
    Timothy An-thy Chan, Zhenghe Wang, Long H. Dang, Bert Vogelstein, Kenneth W. Kinzler · 2002 · Proceedings of the National Academy of Sciences
  78. Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity
    Bipin C. Dash, Wafik S. El‐Deiry · 2005 · Molecular and Cellular Biology
  79. Gene Discovery Using the Serial Analysis of Gene Expression Technique: Implications for Cancer Research
    Kornélia Polyák, Gregory Joseph Riggins · 2001 · Journal of Clinical Oncology
  80. Role of keratinocyte–fibroblast cross‐talk in development of hypertrophic scar
    Aziz Ghahary, Abdi Ghaffari · 2007 · Wound Repair and Regeneration
  81. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases
    Maria Fe Paz · 2003 · Human Molecular Genetics
  82. Biological determinants of radioresistance and their remediation in pancreatic cancer
    Parthasarathy Seshacharyulu, Michael J. Baine, Joshua J. Souchek, Melanie Menning, Sukhwinder Kaur, Ying Yan, Michel M. Ouellette, Maneesh Jain, Chi H. Lin, Surinder K. Batra · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  83. Requirement of Krüppel-like Factor 4 in Preventing Entry into Mitosis following DNA Damage
    Hong Seok Yoon, Vincent W. Yang · 2004 · Journal of Biological Chemistry
  84. Post-translational modification of 14-3-3 isoforms and regulation of cellular function
    Alastair Aitken · 2011 · Seminars in Cell and Developmental Biology
  85. Keratinocyte-Releasable Stratifin Functions as a Potent Collagenase-Stimulating Factor in Fibroblasts
    Aziz Ghahary, Feridoun Karimi‐Busheri, Yvonne Marcoux, Yunyaun Li, Edward E. Tredget, Liang Li, Jing Zheng, Ali Karami, Bernd O. Keller, Michael Weinfeld et al. · 2004 · Journal of Investigative Dermatology
  86. Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine
    Darko Curman, Bruno Cinel, David E. Williams, Natalie T. Rundle, Wesley D. Block, Aaron A. Goodarzi, James R. A. Hutchins, Paul R. Clarke, Bin-Bing Zhou, Susan P. Lees‐Miller et al. · 2001 · Journal of Biological Chemistry
  87. 14-3-3σ Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group
    José Luis Ramírez, Rafael Rosell, Miquel Tarón, María Sanchez-Ronco, Vicente Alberola, Ramon de las Peñas, José Miguel Sánchez, Teresa Morán, Carlos Camps, Bartomeu Massutí et al. · 2005 · Journal of Clinical Oncology
  88. How protein kinases co-ordinate mitosis in animal cells
    Hoi Tang Ma, Randy Y.C. Poon · 2011 · Biochemical Journal
  89. Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status
    Roberta Magrini, Mandar Bhonde, Marie‐Luise Hanski, Michael Notter, Hans Scherübl, Clement Richard Boland, Martin Zeitz, Christoph HANSKI · 2002 · International Journal of Cancer
  90. The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G 2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents
    Yuichi Hirose, Makoto Katayama, David Stokoe, Daphne Adele Haas-Kogan, Mitchel Stuart Berger, Russell O. Pieper · 2003 · Molecular and Cellular Biology
  91. Genetic knockouts and knockins in human somatic cells
    Carlo Rago, Bert Vogelstein, Fred Bunz · 2007 · Nature Protocols
  92. Intracellular signal transduction of cells in response to carcinogenic metals
    Fei Chen, Xianglin Shi · 2002 · Critical Reviews in Oncology/Hematology
  93. Chemotherapy and signaling
    Tetyana Bagnyukova, Ilya G. Serebriiskii, Yan Zhou, Elizabeth A. Hopper-Borge, Erica A. Golemis, Igor A. Astsaturov · 2010 · Cancer Biology & Therapy
  94. Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G2/M arrest or apoptosis
    Xiaolong Yang, Daming Li, Weili Chen, Tian Xu · 2001 · Oncogene
  95. p53 and Cell Cycle Effects After DNA Damage
    Emir Senturk, James J. Manfredi · 2012 · Methods in molecular biology
  96. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
    Sen Yu, Chunyu Zhang, Keping Xie · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  97. Adenovirus and cell cycle control
    Haggit Ben-Israel · 2002 · Frontiers in bioscience
  98. Identification of 14-3-3σ as a Contributor to Drug Resistance in Human Breast Cancer Cells Using Functional Proteomic Analysis
    Yang Liu, Hailan Liu, Baoguang Han, Jian‐Ting Zhang · 2006 · Cancer Research
  99. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
    Yi Fu Zhou, Fuad G. Gwadry, William C. Reinhold, Lance David Miller, Lawrence H. Smith, Uwe Scherf, Edison T. Liu, Kurt W. Kohn, Yves G. Pommier, John N. Weinstein · 2002 · PubMed
  100. The Fbw7 and BetaTRCP E3 ubiquitin ligases and their roles in tumorigenesis
    Alan, W Lau · 2012 · Frontiers in bioscience